Danimer Scientific, INC Schedule 13G passive stakes
Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.
Armistice Capital, LLC and Steven Boyd have filed an amended Schedule 13G, disclosing a shared beneficial ownership of 9.99% of Danimer Scientific, Inc.'s Class A Common stock as of March 31, 2025.
Armistice Capital, LLC and Steven Boyd have filed an amended Schedule 13G, reporting a shared beneficial ownership of 5.50% of Danimer Scientific, Inc.'s Class A Common stock as of December 31, 2024.